Table 3.
Multivariate analysis assessing the impact of MD adherence and nutritional status to recurrence-free patients’ survival.
| Characteristics | Recurrence-Free Survival | |
|---|---|---|
| HR * (95% CI **) | p-Value | |
| Age (below/over median value) | 1.10 (0.38–3.03) | p = 0.558 |
| BMI (normal weight/overweight and obese) | 3.07 (2.12–4.91) | p = 0.002 |
| Histological type (ductal/lobular) | 2.98 (1.48–5.23) | p = 0.043 |
| Histological grade (high and medium/Low) | 1.35 (0.24–2.43) | p = 0.312 |
| Tumor size (≤2 cm/>2 cm) | 0.94 (0.13–5.77) | p = 0.748 |
| Presence of lymph node metastases (No/Yes) | 1.06 (0.20–5.89) | p = 0.620 |
| Presence of distant metastases (No/Yes) | 0.97 (0.21–5.12) | p = 0.407 |
| Physical activity levels (low/moderate and high) | 1.12 (0.32–2.59) | p = 0.573 |
| Health-related quality of life (low/high) | 0.66 (0.21–1.54) | p = 0.112 |
| MD adherence | p = 0.017 | |
| Low (reference) | 1.00 | |
| Moderate | 0.47 (0.18–0.79) | |
| High | 0.39 (0.15–0.72) | |
| Nutritional status | p = 0.046 | |
| Malnutrition (reference) | 1.00 | |
| Risk of malnutrition | 0.62 (0.21–1.02) | |
| Well-nourished | 0.57 (0.18–0.97) | |
* Hazard ratio: HR. ** CI: Confidence interval.